German firms outline "consultancy" role
This article was originally published in Clinica
Executive Summary
Against a backdrop of continued under-investment in German healthcare, medical technology companies - and their customers - are looking increasingly to alternative financing instruments to ensure that the product of their R&D enters into commercial circulation.